Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2003
06/24/2003US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood
06/24/2003CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
06/24/2003CA1341433C Purification of interleukin 1
06/19/2003WO2003050283A2 A structure for presenting desired peptide sequences
06/19/2003WO2003050275A2 Method of isolation and purification of trypsin from pronase and use thereof
06/19/2003WO2003050274A2 Process for harvesting crystalline particles from fermentation broth
06/19/2003WO2003050265A2 Compositions and methods for normalizing assays
06/19/2003WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003WO2003050254A2 Novel chimeric tnf ligands
06/19/2003WO2003050236A2 Human genes and gene expression products isolated from human prostate
06/19/2003WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003WO2003049525A2 Methods and materials for the production of organic products in cells of $i(candida) species
06/19/2003WO2002094864A3 Human cdnas and proteins and uses thereof
06/19/2003WO2002077237A3 Transporters and ion channels
06/19/2003WO2002048376A3 Bacterial host strains
06/19/2003WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003US20030114659 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
06/19/2003US20030114658 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
06/19/2003US20030114652 Hybrid polypeptide; genetic engineering
06/19/2003US20030114648 Method of protein purification
06/19/2003US20030114398 Monoclonal antiidiotype antibody 1A7 eliciting an anti-ganglioside GD2 response and overcomes immune tolerance; detecting an anti-GD2 antibody bound to a tumor cell; kits; melanoma, neuroblastoma, glioma, soft tissue sarcoma
06/19/2003US20030113940 Antibodies specific for nanotubes and related methods and compositions
06/19/2003US20030113909 G protein coupled receptor protein, production and use thereof
06/19/2003US20030113896 Medical diagnosis; detection of antibodies
06/19/2003US20030113895 Proteases from gram-positive organisms
06/19/2003US20030113873 Screening modulators of G-protein coupled binding proteins; analgesics; muscle-relaxants; cognition activators; learning enhancement
06/19/2003US20030113872 Vasopermeability-enhancing conjugates
06/19/2003US20030113871 Glycoprotein hormones; human chorionic gonadotropin; carboxy terminal peptides (ctp); increaseing half life of polypeptides; antipernicious anemia drugs
06/19/2003US20030113870 Polypeptides homologous to VEGF and BMP1
06/19/2003US20030113868 Human metabotropic glutamate receptor subtype mGluR7b
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113864 Induction of chondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113863 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113862 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113861 Induction of chondrocyte differentiation/proliferation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113859 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113858 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113857 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113856 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113855 Induction of chondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113851 Induction of chondrocyte differentaition/proliferation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
06/19/2003US20030113849 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113848 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113843 For stimulating release of tumor necrosis factor, and/or cell proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; antiinflammatory agents; anticarcingenic agents; antitumor agents; cancer diagnosis
06/19/2003US20030113842 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113838 Epidermal growth factor; antitumor agents; antiproliferative agents; antiinflammatory agents; mitogen-activated protein kinases
06/19/2003US20030113835 Methods for protein synthesis, protein screening and retrieval of protein function
06/19/2003US20030113808 Apolipoprotein biopolymer markers predictive of alzheimers disease
06/19/2003US20030113803 Orphan receptor
06/19/2003US20030113795 Membrane protein; cytokines; antitumor agents; anticarcinogenic agents; antiinflammatory agents; cancer diagnosis
06/19/2003US20030113793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113780 Antibodies to crosslinkers and methods for using the same
06/19/2003US20030113772 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113771 DNA encoding human alpha 1 adrenergic receptors and uses thereof
06/19/2003US20030113764 Compositions and methods for the treatment of tumors
06/19/2003US20030113752 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
06/19/2003US20030113743 Method for detection of micrometastatic prostate cancer
06/19/2003US20030113738 Replication; hybridization; drug screening
06/19/2003US20030113719 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113718 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/19/2003US20030113403 Hydrolyzing a protein using an enzyme and a thermotolerant lactic acid bacteria strain that provides glutaminase activity. seasoning or flavor for culinary or petfood products.
06/19/2003US20030113339 Methods to improve immunogenicity of antigens and specificity of antibodies
06/19/2003US20030113337 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
06/19/2003US20030113334 Cytotoxic antibodies specifically bind to proteins which were expressed in lymphatic tumors
06/19/2003US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003US20030113316 Stable lyophilized pharmaceutical formulation of IgG antibodies
06/19/2003CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003CA2692325A1 Islet cells from human embryonic stem cells
06/19/2003CA2474152A1 Methods and materials for the production of organic products in cells of candida species
06/19/2003CA2472054A1 Compositions and methods for normalizing assays
06/19/2003CA2469802A1 A structure for presenting desired peptide sequences
06/19/2003CA2469494A1 Novel chimeric tnf ligands
06/19/2003CA2469484A1 Method of isolation and purification of trypsin from pronase and use thereof
06/19/2003CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003CA2469027A1 Human genes and gene expression products isolated from human prostate
06/18/2003EP1319712A2 Fusion protein having enhanced in vivo activity of erythropoietin
06/18/2003EP1319711A2 Production of pharmaceutical-grade plasmid DNA
06/18/2003EP1319182A2 G-csf analog compositions and methods
06/18/2003EP1319074A2 Process for producing peptides by using i in vitro /i transcription/translation system
06/18/2003EP1319073A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
06/18/2003EP1319072A2 G-protein coupled receptor hfrbn63
06/18/2003EP1319071A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/18/2003EP1319067A2 Human coagulation factor vii variants
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319022A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
06/18/2003EP1318834A2 Compositions comprising mixtures of human cytokines and methods of producing the same
06/18/2003EP1181306A4 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
06/18/2003EP1157125A4 Monkey gonadotropin releasing hormone receptor
06/18/2003EP0891427B1 Expression of hgv antigens and their use
06/18/2003EP0821739B1 An adenovirus helper-virus system
06/18/2003EP0757993B1 Preventive for circulatory diseases
06/18/2003EP0538404B1 Fibroblast growth factor receptors
06/18/2003CN1425136A Assay of isomerised and/or optically inverted proteins and protein fragments
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 1125